Antoon H. Van Lierop
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Long-term clinical and bone mineral density changes of adult patients with sclerostin deficiency due to van Buchem disease: a follow-up study.
Journal: JBMR plus
Published: October 03, 2024
Low sclerostin levels after long-term remission of acromegaly.
Journal: Endocrine
Published: May 04, 2021
Effects of progesterone therapy on serum sclerostin levels in healthy menopausal women: a 3-month randomized, placebo-controlled clinical trial.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: December 17, 2019
hypercalcaemia due to a calcitriol-producing neuroendocrine tumour.
Journal: Journal of surgical case reports
Published: August 27, 2019
Serum Dickkopf 1 levels in sclerostin deficiency.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 05, 2013
Sclerostin deficiency is linked to altered bone composition.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: November 13, 2013
Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 19, 2013
Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 31, 2012
Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: June 18, 2012
Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
Journal: European journal of endocrinology
Published: January 24, 2012
Last Updated: 09/26/2026